PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
This Quarter Return
+29.36%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$3.44B
AUM Growth
+$3.44B
Cap. Flow
+$258M
Cap. Flow %
7.49%
Top 10 Hldgs %
43.94%
Holding
127
New
15
Increased
25
Reduced
25
Closed
9
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
DRIO icon
101
DarioHealth
DRIO
$22.6M
$1.52M 0.04%
327,869
TARA icon
102
Protara Therapeutics
TARA
$125M
$859K 0.02%
290,051
HYPR icon
103
Hyperfine
HYPR
$88M
$751K 0.02%
927,388
-207,000
-18% -$168K
SONX
104
DELISTED
Sonendo, Inc.
SONX
$655K 0.02%
612,204
-36,301
-6% -$38.8K
PRVB
105
DELISTED
Provention Bio, Inc. Common Stock
PRVB
$498K 0.01%
110,728
ICVX
106
DELISTED
Icosavax, Inc. Common Stock
ICVX
$296K 0.01%
93,591
-949,259
-91% -$3M
MOTS
107
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$221K 0.01%
90,027
-1,710,515
-95%
EQRXW
108
DELISTED
EQRx, Inc. Warrant
EQRXW
$205K 0.01%
250,000
AGRX
109
DELISTED
Agile Therapeutics, Inc
AGRX
$158K ﹤0.01%
532,361
CMAXW
110
DELISTED
CareMax, Inc. Warrant
CMAXW
$113K ﹤0.01%
60,000
NEPT
111
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$87K ﹤0.01%
57,142
SRZNW icon
112
Surrozen, Inc. Warrant
SRZNW
$71.9K
$31K ﹤0.01%
166,666
SRZN icon
113
Surrozen
SRZN
$107M
$12K ﹤0.01%
6,017
ZY
114
DELISTED
Zymergen Inc. Common Stock
ZY
-883,332
Closed -$1.09M
TCDA
115
DELISTED
Tricida, Inc. Common Stock
TCDA
0
FUSN
116
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
-1,052,445
Closed -$2.62M
XBI icon
117
SPDR S&P Biotech ETF
XBI
$5.29B
0
SAVA icon
118
Cassava Sciences
SAVA
$107M
0
RACE icon
119
Ferrari
RACE
$88.2B
-6,200
Closed -$1.14M
PRVA icon
120
Privia Health
PRVA
$2.84B
-273,423
Closed -$7.96M
NUVB icon
121
Nuvation Bio
NUVB
$1.08B
-1,769,701
Closed -$5.73M
MGNX icon
122
MacroGenics
MGNX
$121M
-1,227,202
Closed -$3.62M
LLY icon
123
Eli Lilly
LLY
$661B
-100,000
Closed -$32.4M
DAWN icon
124
Day One Biopharmaceuticals
DAWN
$766M
-556,047
Closed -$9.95M
ALNY icon
125
Alnylam Pharmaceuticals
ALNY
$58.6B
-172,991
Closed -$25.2M